The proposed mechanism (from the single rat study) is that fadogia's alkaloids and saponins stimulate Leydig cells to produce more testosterone, similar to how LH works. However, the same stimulation appears to damage those cells at effective doses. It's essentially overstimulating the testosterone-producing machinery until it breaks. The alkaloids involved have not been fully characterized, the dose-response curve in humans is completely unknown, and there is no safety margin established.
Insufficient data to classify any interaction as "low-risk", ALL interactions are unknown.
Independently graded against 173,636 indexed supplements with 177 published clinical interactions, sourced from PubMed, FDA CAERS, openFDA, and NIH DSLD | Last updated:
Not medical advice. Based on published clinical research and systematic reviews.